Prof. Magnus Ingelman-Sundberg Karolinska Institutet, Sweden

2 Talks

Magnus Ingelman-Sundberg, PhD; BSc.Med is Professor of Molecular Toxicology and research group leader in Pharmacogenetics at the Department of Physiology and Pharmacology, Karolinska Institutet. He has more than 500 original papers and a h-factor of 94 (ISI) or 121 (Google Scholar). Assigned “Highly Cited Researcher” for 2014, 2015, 2016, 2017,... read more2021 and 2022 by Thomson & Reuters/Clarivate. He was a member of The Nobel Assembly at Karolinska Institutet 2008-2018 and a member of Editorial Advisory Boards of e.g. Trends in Pharmacological Sciences (Edit Board), Pharmacogenetics and Genomics, Pharmacogenomics, Drug Metabolism Reviews, Drug Metabolism and Disposition, Human Genomics. He has received numerous Awards, most recently the 2018 BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology and an honorary doctorship at SydDansk University. His research focuses on genetics, polymorphism, regulation, function and toxicology of the hepatic ADME system with aims at understanding interindividual differences in drug response. Furthermore he develops novel hepatic in vitro systems for studying liver function, liver diseases and validation of hepatic drug targets.